These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2141948)

  • 1. The 5HT3 antagonist GR38032F is highly toxic in DBA/2 mice.
    Hendrie CA
    Psychopharmacology (Berl); 1990; 101(3):429-30. PubMed ID: 2141948
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
    Goudie AJ; Leathley MJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):179-86. PubMed ID: 1979273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret.
    Hawthorn J; Cunningham D
    Br J Cancer; 1990 Jan; 61(1):56-60. PubMed ID: 2137008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting.
    Grunberg SM; Stevenson LL; Russell CA; McDermed JE
    J Clin Oncol; 1989 Aug; 7(8):1137-41. PubMed ID: 2526864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice.
    Rodgers RJ; Shepherd JK; Randall JI
    Neuropharmacology; 1990 Jan; 29(1):17-23. PubMed ID: 2137563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats.
    Peltier R; Schenk S
    Pharmacol Biochem Behav; 1991 May; 39(1):133-6. PubMed ID: 1833779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5-hydroxytryptamine on external carotid nerve activity and its blockade by GR38032F in anesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Saito H
    Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):39-45. PubMed ID: 1839326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Eur J Pharmacol; 2014 Dec; 744():59-66. PubMed ID: 25284215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig.
    Costall B; Gunning SJ; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Jun; 91(2):263-4. PubMed ID: 2955843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Br J Pharmacol; 1989 Feb; 96(2):325-32. PubMed ID: 2522335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of refractory, chemotherapy-induced emesis with the serotonin antagonist ondansetron (GR38032F).
    Campora E; Vidili G; Oliva C; Ardizzoni A; Rosso R
    Oncology; 1991; 48(5):403-5. PubMed ID: 1836058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
    Yoshioka M
    J Pharmacol Exp Ther; 1989 Aug; 250(2):637-41. PubMed ID: 2527299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
    Jones BJ; Costall B; Domeney AM; Kelly ME; Naylor RJ; Oakley NR; Tyers MB
    Br J Pharmacol; 1988 Apr; 93(4):985-93. PubMed ID: 2898961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze.
    Vasar E; Peuranen E; Oöpik T; Harro J; Männistö PT
    Psychopharmacology (Berl); 1993; 110(1-2):213-8. PubMed ID: 7870888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B
    Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1990 May; 36(1):97-104. PubMed ID: 2140900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.